ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis

Hu, Yuan; Wang, Peng; Dai, Wenli*1
BMC Pulmonary Medicine2023-3-7DOI: 10.1186/s12890-023-02377-9
2被引7阅读
引用收藏
分享

摘要

BackgroundPSMA PET/CT has shown excellent results in imaging of prostate cancer. However, some nonprostatic malignancies can also demonstrate (18) F-PSMA uptake, including primary lung cancer. (18) F-FDG PET/CT is widely employed in initial staging, response to therapy and follow-up assessment for lung cancer. Here we present an interesting case report on the different patterns of PSMA and FDG uptake between primary lung cancer and metastatic intrathoracic lymph node metastases in a patient with concurrent metastatic prostate cancer.Case presentationA 70-year-old male underwent (18) F-FDG PET/CT and (18) F-PSMA-1007 PET/CT imaging due to suspicion primary lung cancer and prostate cancer. The patient eventually was diagnosed with non-small cell lung cancer (NSCLC) with mediastinal lymph node metastases and prostate cancer with left iliac lymph node and multiple bone metastases. Interestingly, our imaging revealed different patterns of tumor uptake detected on (18) F-FDG and (18) F-PSMA-1007 PET/CT in primary lung cancer and lymph node metastases. The primary lung lesion showed intense FDG uptake, and mild uptake with (18) F-PSMA-1007. Whereas the mediastinal lymph node metastases showed both intense FDG and PSMA uptake. The prostate lesion, left iliac lymph node, and multiple bone lesions showed significant PSMA uptake and negative FDG uptake.ConclusionIn this case, there was a homogeneity of (18) F-FDG intense uptake between LC and metastatic lymph nodes, but a heterogeneity in (18) F-PSMA-1007 uptake. It illustrated that these molecular probes reflect the diversity of tumor microenvironments, which may help us understand the differences of the tumor response to treatment.

学科与关键词

关键词
F-18-PSMA-1007F-18-FDGPETCTPrimary lung cancerLymph node metastases
相关
加载中…
  • Diagnostic accuracy of 18F-PSMA-1007 PET/CT for prostate 18 cancer in primary staging and biochemical recurrence with different serum PSA levels: A systematic review and meta- analysis
    Liu, Xue; Wang, Qi; Zhang, Bao; Jiang, Tao*; Zeng, Wenbing*Hellenic Journal of Nuclear Medicine, 2022, 25(1): 88-102.被引 4
  • Diagnostic value of integrated 18F-PSMA-1007 PET/MRI compared with that of biparametric MRI for the detection of prostate cancer
    Zeng, Yuping; Leng, Xiaoming; Liao, Hengbin; Jiang, Guihua*; Chen, Ping*Prostate International, 2022, 10(2): 108-116.被引 3
  • Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Advanced Lung Cancer
    Wang, Lijuan; Tang, Ganghua; Hu, Kongzhen; Liu, Xinran; Zhou, Wenlan; Li, Hongsheng; Huang, Shun; Han, Yanjiang; Chen, Li; Zhong, Jinmei; Wu, Hubing*RADIOLOGY, 2022, 303(1): 191-199.被引 53
查看全部 →

发表信息

论文状态
公开发表
期刊
BMC Pulmonary Medicine
发表日期
2023-03-07
卷期
第 23 卷, 第 1 期
页码
73
DOI
10.1186/s12890-023-02377-9
语言
ENGLISH
成果收录
SCIE

作者

  • H

    Hu, Yuan (第一作者)

    1 · china three gorges univ

  • W

    Wang, Peng

    1 · china three gorges univ

查看全部 3 位作者收起作者
  • D

    Dai, Wenli (通讯)

    1 · china three gorges univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417